Orchestra BioMed Inc.

NASDAQ: OBIO · Real-Time Price · USD
2.56
-0.10 (-3.76%)
At close: Aug 15, 2025, 3:59 PM
2.57
0.19%
After-hours: Aug 15, 2025, 07:58 PM EDT

Orchestra BioMed Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-69.7M -66.32M -61.02M -57.69M -55.58M -51.64M -49.12M -46.05M -33.42M -29.22M -24.01M -14.35M -18.92M -17.23M -15.04M -14.95M -9.69M -3.54M
Depreciation & Amortization
324K 317K 308K 296K 291K 290K 287K 285K 268K 245K 222K 200K 192K 186K 181K 133K 87K 43K
Stock-Based Compensation
11.48M 10.99M 10.62M 8.63M 9.78M 8.72M 7.63M 7.57M 6.28M 4.83M 3.41M 2.59M 433K 311K 302K 263K 196K 61K
Other Working Capital
-8.49M -5.45M -6.32M -4.95M 1.53M -2.23M -1.35M -1.22M -1.47M -966.07K -663.07K -639.86K -901.79K -734.79K 83.21K 20K 40K 102K
Other Non-Cash Items
1.75M 1.47M 906K 1.97M 575K -160K -546K -751K -11.62K 1.03M 2.08M 228.34K 743.97K 2.25M -269.03K -265K -653K -2.33M
Deferred Income Tax
n/a n/a n/a -1.08M -1.38M -1.35M -1.07M -1.85M -3.83M -3.9M -3.81M -1.95M 332K 365K n/a n/a n/a n/a
Change in Working Capital
-3.23M -519K -1.36M -116K 1.73M -725K -3.31M -3.1M -3.47M -4.65M -494.07K -524.86K -838.79K -386.79K 57.21K -6K 66K 179K
Operating Cash Flow
-59.38M -54.06M -50.56M -47.99M -44.58M -44.86M -46.13M -43.9M -34.19M -31.66M -22.6M -13.89M -18.15M -14.59M -14.85M -14.82M -10M -5.59M
Capital Expenditures
-320K -393K -289K -180K -131K -51K -78K -135K -340K -579K -591K -661K -490K -224K -274K -150K -97K -97K
Cash Acquisitions
-602K -602K -602K -33.15M -46.11M -110.31M -110.31M -77.17M -64.2M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-33.16M -51.81M -72.65M -56.34M -84.87M -122.27M -142.03M -201.4M -162.87M -107.03M -63.53M -208K -208K n/a n/a n/a n/a n/a
Sales Maturities Of Investments
60.24M 73.04M 86.63M 106.51M 147.38M 182.4M 152.8M 115.69M 156.79M 92.59M 92.59M 92.59M n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a 33.15M 46.11M 110.31M 66.82M -29.65M -42.39M -106.8M -63.31M -197K 5.91M 12.45M 13.29M 13.5M 7.17M 840K
Investing Cash Flow
26.16M 20.23M 13.09M 49.99M 62.38M 60.08M 10.69M -85.84M -6.2M -14.79M 28.69M 91.73M 5.42M 12.23M 13.02M 13.35M 7.08M 743K
Debt Repayment
15M 15M 15M -10.85M -10.85M -10.85M -10.85M n/a n/a 4.55M 3.55M 2.55M 1.55M -4M -4M -3M -2M -1M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a -109.83M -202.42M -202.42M -202.42M -92.59M n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-1.92M -1.49M -1.1M n/a n/a 86K 56.91M 51.82M 49.32M 48.21M -10.13M -5.03M -2.53M -1.5M 7K n/a n/a n/a
Financial Cash Flow
28.26M 28.86M 29.17M 4.53M -10.5M -10.59M 46.22M 51.82M -40.77M 45.22M 13.16M 17.26M 108.85M 21.77M -3.99M -3M -2M -1M
Net Cash Flow
-4.96M -4.98M -8.3M 6.53M 7.3M 4.63M 10.78M -77.92M -81.16M -1.23M 19.25M 96.43M 97.45M 20.74M -4.5M -4.47M -4.92M -5.84M
Free Cash Flow
-59.7M -54.45M -50.85M -48.17M -44.71M -44.91M -46.2M -44.03M -34.53M -32.24M -23.2M -14.55M -18.64M -14.81M -15.13M -14.97M -10.09M -5.68M